Clik here to view.
[IQX] Application for Quotation of Additional Securities
Application for Quotation of Additional Securities for Directors Shares Approved at EGM and Employee Shares Issued under Employee Share Plan - Top 20 & Holding Analysis
View ArticleClik here to view.
[IQX] Application for Quotation of Additional Securities From Share Split,...
Application for Quotation of Additional Securities From Share Split, Top 20 & Holding Analysis
View ArticleClik here to view.
[IQX] Directors Change of Interest - G. Syrmalis
Directors Change of Interest - G. Syrmalis
View ArticleClik here to view.
[IQX] Change in Direcror's Interests - J Stratilas
Change in Direcror's Interests - J Stratilas
View ArticleClik here to view.
[IQX] Change in Direcror's Interests - P. Simpson
Change in Direcror's Interests - P. Simpson
View ArticleClik here to view.
Clik here to view.
Clik here to view.
Clik here to view.
[IQX] Notice of Annual General Meeting & Proxy Form
Notice of Annual General Meeting & Proxy Form
View ArticleClik here to view.
[IQX] Annual Report to the Shareholders (Price Sensitive)
Annual Report to the Shareholders
View ArticleClik here to view.
Clik here to view.
Clik here to view.
[IQX] Request Trading Halt (Price Sensitive)
Request Trading Halt Regarding License from Wyss Institute at Harvard University
View ArticleClik here to view.
Clik here to view.
[IQX] Notice of Annual General Meeting & Proxy Form
Notice of Annual General Meeting & Proxy Form
View ArticleClik here to view.
[IQX] iQX Limited Appointment/Resignation of CoSec
iQX Limited Appointment/Resignation of Company Secretary 12 January 2021
View ArticleClik here to view.
Clik here to view.
Clik here to view.
Clik here to view.
Clik here to view.
Clik here to view.
[IQX] iQX Limited Half-yearly Report (Price Sensitive)
iQx Limited Half-yearly Financial Report
View ArticleClik here to view.
[IQX] Progress of clinical programs
Progress of clinical programs by its subsidiary companies; Life Science Biosensor Diagnostics Pty Ltd and OncoTex Inc.
View ArticleClik here to view.
[IQX] Appointment / Resignation of Company Secretary
Appointment / Resignation of Company Secretary
View ArticleClik here to view.
[IQX] Portfolio Company Awarded $6.3M Federal Govt Grant (Price Sensitive)
GBS awarded $6.3 million Federal Government science grant to manufacture biosensor technology.
View ArticleClik here to view.
[IQX] Annual Nominated Adviser Statement - 2021-2022
Annual Nominated Adviser Statement - 2021-2022
View ArticleClik here to view.
Clik here to view.
[IQX] LSBD Update on Biosensor FDA Pre-Submission (Price Sensitive)
Filed a Pre-Submission package with the United States (US) Food and Drug Administration (FDA).
View ArticleClik here to view.
[IQX] Notice of Annual General Meeting & Proxy Form
Notice of Annual General Meeting & Proxy Form
View ArticleClik here to view.
Clik here to view.
[IQX] OncoTEX Gold Compound Licensing (Price Sensitive)
Gold Technology for Immune Response Cancer Therapy Licensed to OncoTEX
View ArticleClik here to view.
[IQX] Wyss Validation Study SARS-CoV-2 (Price Sensitive)
Wyss Validation Study SARS-CoV-2
View ArticleClik here to view.
[IQX] IQX Chairman's Address
IQX Chairman's Address to Shareholders AGM: 19 November 2021
View ArticleClik here to view.
Clik here to view.
[IQX] Director Resignation and Appointment
Appointment of Director Vincenzo Milazzo and Resignation of Director John Stratilas
View ArticleClik here to view.
[IQX] Final Director's Interest-John Stratilas
Final Director's Interest-John Stratilas
View ArticleClik here to view.
[IQX] Initial Director's Interest-Vincenzo Milazzo
Initial Director's Interest-Vincenzo Milazzo
View ArticleClik here to view.
[IQX] FDA Breakthrough Devices Designation (Price Sensitive)
FDA Breakthrough Devices Designation application to fast track rapid saliva glucose testing
View ArticleClik here to view.
[IQX] Appointment/Resignation of Company Secretary
Appointment/Resignation of Company Secretary
View ArticleClik here to view.
[IQX] Director's Declaration and Undertaking
Director's declaration and undertaking on behalf of Vincenzo Milazzo
View ArticleClik here to view.
[IQX] Worldwide license for Harvard Uni’s eRapid Technology (Price Sensitive)
Antisoma Therapeutics secures worldwide license for Harvard University’s eRapid technology for at-home diagnostic testing
View ArticleClik here to view.
[IQX] IQX Limited Seeks Voluntary Admin today to Restructure (Price Sensitive)
IQX Limited seeks Voluntary Administration today to restructure
View ArticleClik here to view.
[IQX] The phone number for the VA has now been corrected (Price Sensitive)
The phone number for the Voluntary Administrator was incorrect and nothing else has changed.
View ArticleClik here to view.
[IQX] Continued Suspension - Failure to lodge Half Yearly Financial...
Continued Suspension - Failure to lodge Half Yearly Financial Statements- 31 December 2021
View ArticleClik here to view.
[IQX] Deferral Financial Reporting Obligations (Price Sensitive)
Deferral Financial Reporting Obligations
View ArticleClik here to view.
Clik here to view.
[IQX] Execution Of Deed Of Company Arrangement (Price Sensitive)
Execution Of Deed Of Company Arrangement
View ArticleClik here to view.
[IQX] Continued Suspension - Non-payment of Annual Listing Fee 2022-2023...
Continued Suspension - Non-payment of Annual Listing Fee 2022-2023
View ArticleClik here to view.
[IQX] Continued Suspensison - Failure to lodge Preliminary Final Report for...
Continued Suspensison - Failure to lodge Preliminary Final Report for 30 June 2022
View ArticleClik here to view.
[IQX] Company Removed from Official List - Failure to pay Annual Listing Fee...
Company Removed from Official List - Failure to pay Annual Listing Fee - 2022/2023 - Delisted 19th of September 2022
View Article
